Illumina Wants 'Indefensible' $334M DNA IP Verdict Tossed
Illumina urged a Delaware federal judge Friday to overturn a verdict last month finding that the biotechnology company willfully infringed two Complete Genomics Inc. DNA sequencing patents and owes $334 million...To view the full article, register now.
Already a subscriber? Click here to view full article